Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Victor Diaz Perez will be responsible for the solid state chemistry and physical sciences business
October 27, 2016
By: Tim Wright
Editor-in-Chief, Contract Pharma
Contract development and manufacturing organization (CDMO) Almac Group has appointed Dr. Victor Diaz Perez as head of physical sciences. Dr. Diaz will further complement the existing physical sciences team bringing his experience in research and development within solid state chemistry. He will be responsible for Almac’s solid state chemistry and physical sciences business and tasked with strengthening the overarching chemical development strategy. Before joining Almac Dr. Diaz spent ten years with Pharmorphix, now part of Johnson Matthey, a global contract research organization (CRO) providing solid state services for the pharmaceutical and fine chemicals industry. There he worked as projects director before being appointed as site manager/operations director. He was also a key player in the acquisition of Pharmorphix by Johnson Matthey from Sigma Aldrich, which completed in October 2015. Before joining Pharmorphix, Dr. Diaz worked for over seven years as a medicinal chemist at Medivir AB, both within the hit identification and lead optimization teams and, prior to that, he worked at High Force Research providing chemical synthesis and R&D service to the pharmaceutical, agrochemical and fine chemical industries. “Victor’s combined experience within physical sciences and his extensive knowledge of strategic management makes him a valuable addition to our team,” said John Robson, vice president quality operations, Almac Sciences. “We are delighted he has accepted this role with Almac and we look forward to working together to continue to develop our global business and provide best in class, innovative drug development solutions to our growing client base.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !